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The consumption of plant food supplements (PFS) has been growing globally, with an increase of
misleading labeling and fraudulent practices also being reported. Recently, the use of molecular biology
techniques has been proposed to detect botanical adulterations, one of the possible frauds in PFS.
However, difﬁculties in recovering DNA from some PFS samples have been described. Aiming at using
DNA-based methods for the unequivocal identiﬁcation of plant species in PFS, adequate DNA isolation is
required. However, PFS often contain pharmaceutical excipients known to have adsorbent properties that
might interfere with DNA extraction. Thus, the aim of this work was to assess the effect of different
excipients (talc, silica, iron oxide and titanium dioxide) on the recovery/ampliﬁcation of DNA. For that
purpose, known amounts of template maize DNA were spiked either to PFS or to model mixtures of
excipients and quantiﬁed by real-time PCR. The tested excipients evidenced clear adsorption phenomena
that justify the hampering effect on DNA extraction from PFS. The use of either 10% talc or 0.5% dyes
completely adsorbed DNA, resulting in negative PCR ampliﬁcations. For the ﬁrst time, pharmaceutical
excipients were shown to affect DNA extraction explaining the inability of recovering DNA from some PFS
samples in previous studies.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
During the last years, medicinal plants and products thereof
have become increasingly available in the European Union (EU)
market as ingredients in formulations sold as plant food supple-
ments (PFS). This type of products has been growing in popularity,
with its increased use being associatedwith a variety of factors such
as the perception that plant products are safe and that “natural” is
healthy. The mistrust in conventional medicine and a rising ten-
dency for self-medication are also associated factors [1]. Addi-
tionally, trade globalization has brought to Europe a wide range of
plants traditionally used in other continents, which are now offered
in several popular PFS marketed in European countries [1]. For
these reasons, the market for food supplements has been growingde Bragança, Campus de Sta.
bel.mafra@ff.up.pt (I. Mafra).during the last years, with a consequent demand for plant material.
This can result in a higher number of frauds and/or in increased
possibility of unintentional swap of plants due to misidentiﬁcation
of wild collected specimens. Among possible adulterations of PFS,
the intentional addition of plant ﬁllers to increase product bulk and
the substitution of high priced medicinal plants by other closely
related/similar species should be considered [2,3]. In both cases,
namely adulterations or unintentional swap of plants, the PFS
integrity might be compromised by the introduction of unknown
phytochemicals arising from the unlabeled plant(s), which can
directly affect the PFS efﬁcacy [4]. Furthermore, the safety of these
products is also jeopardized since cases of possible health risks
resulting from undeclared plants in PFS have already been reported
[5,6].
Therefore, to protect consumers, analytical methodologies that
allow the identiﬁcation of plant species, both in raw botanical
materials and in the ﬁnished products/commercialized PFS, are
required. So far, different methodologies have been proposed for
the identiﬁcation of plant species in PFS, including traditional
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observations) and chemical proﬁling [7e9]. Considering that these
methods are not appropriated for PFS since they generally contain
processed/powdered botanical mixtures [10] recent works have
suggested the use of DNAmolecules as diagnostic markers. As main
advantages, these molecules are present in most cells and they are
not affected by physiological plant conditions, unlike most phyto-
chemical compounds [3,11,12].
DNA-based techniques are considered highly sensitive and
speciﬁc tools, allowing the successful identiﬁcation of plant species,
even in complex and very processed samples [13e16]. However, up
to date, most of DNA methodologies reporting the identiﬁcation of
medicinal plant species essentially concern botanical rawmaterials
and traditional herbal medicines [17e19] with few works being
developed for the authentication of PFS. Newmaster et al. [3] used
DNA barcoding for the authentication of 44 herbal products (41
capsules, 1 tablet and 2 powders) sold in North-America and 50 leaf
samples from different species. The authors were able to recover
barcodes from DNA extracts of all leaf samples, whereas for herbal
products the success rate was 91% (40/44 products). Wallace et al.
[12] used DNA sequence information through standardized DNA
barcoding aiming at the authentication of 95 natural health prod-
ucts, including 70 from plant origin (tea, liquids, root pieces, root
slices, capsules, tablets and caplets). Although the authors used
multiple markers and primer sets, theywere unable to recover DNA
barcodes from 25% of the plant products, from which two were
plant roots, while fourteen were capsules, tablets or caplets. Thus,
DNA ampliﬁcation was not accomplished for a much higher num-
ber of pharmaceutical formulations (14 in a total of 33 capsules,
tablets and caplets), when compared to samples of botanical ma-
terials (2 in a total of 35 samples of teas and roots). This difference
of results can possibly be related to the fact that formulations of PFS
frequently contain pharmaceutical excipients such as diluents,
ﬁllers, binders, glidants, lubricants, pigments and stabilizers [20]. In
particular, some excipients used in the manufacturing of PFS, such
as micronized talc (hydrated magnesium silicate) and silica (silicon
dioxide), are known to have adsorbent properties. As a result, a
hamper effect on the DNA extraction from PFS samples might occur,
compromising the subsequent ampliﬁcation. To the best of our
knowledge, no studies have been carried out regarding the evalu-
ation of possible interferences of pharmaceutical excipients on DNA
extraction yields. Thus, the aim of this work was to ascertain the
effect of different excipients (talc, silica, iron oxide and titanium
dioxide) in the recovery/ampliﬁcation of known amounts of maize
DNA added either to PFS samples or to different mixtures of
pharmaceutical excipients.
2. Materials and methods
2.1. Samples of PFS
PFS were acquired at local pharmacies or gently provided by
some companies (DietMed, Portugal and Distrifa, Portugal). To
evaluate the inﬂuence of pharmaceutical excipients commonly
used in capsules and tablets, four PFSwere carefully chosen in order
to contain: talc and/or silica, titanium dioxide and/or iron oxide.
One of the samples was also speciﬁcally chosenwithout containing
any of the referred excipients for comparative purposes. None of
the ﬁve PFS had maize starch included in their formulations. The
complete description of each PFS composition is presented in
Table 1. PFS were independently grinded and homogenized in
mortars previously treated with DNA decontamination solution
(DNA-ExitusPlus™, AppliChem, Darmstadt, Germany). To assess the
effect of the matrix during DNA extraction, rice powder was also
used.2.2. Mixtures of different pharmaceutical excipients
Several mixtures containing different quantities of the phar-
maceutical excipients under analysis, namely silica, talc, titanium
dioxide and iron oxide, were prepared using microcrystalline cel-
lulose as tablet/capsule diluent. The quantities of the excipients
under study were chosen according to their speciﬁc functions in
tablets/capsules formulations [20]. The complete description of the
assayed mixtures of excipients is included in Table 2. Brieﬂy, a total
of eleven formulations were prepared using talc and/or silica as
glidants/lubricant agents and titanium dioxide and/or iron oxide as
dyes. Since cellulose is not described as having DNA adsorbent
properties, it was used as a bulk excipient (100% microcrystalline
cellulose, without any of the tested excipients). Mixtures contain-
ing 1% and 10% of silica (M1, M2), 1% and 10% of talc (M3, M4), 1% of
silica and 1% talc (M5), 0.5% and 1% of titanium dioxide (M6, M7),
0.5% and 1% of iron oxide (M8, M9) and 1% of titanium dioxide plus
1% of iron oxide (M10) were prepared in cellulose. The mixtures
were independently homogenized in mortars previously treated
with DNA decontamination solution (DNA-ExitusPlus™, Appli-
Chem, Darmstadt, Germany).
2.3. DNA extraction
Portions of 100 mg of each PFS (Table 1) or each pharmaceutical
excipient mixture (Table 2), previously homogenized, were
weighted in sterile reaction tubes. DNA was extracted using the
commercial DNA extraction kit Nucleospin Plant II (Macher-
eyeNagel, Düren, Germany), according to the manufacturer's in-
structions with minor alterations. Before performing DNA
extraction protocol, 100 mL of maize DNA (50 ng) were added to
each PFS, mixture or rice and incubated for 30min at 37 Cwith soft
stirring (300 rpm). After the incubation step, 300 mL of PL2 lysis
solution pre-heated at 65 C were added to each sample. After an
incubation period of 1 h at 65 C with continuous stirring
(1000 rpm), 75 mL of buffer PL3 were mixed in each tube and
incubated for 5 min on ice to completely precipitate the SDS (so-
dium dodecyl sulphate). The samples were centrifuged at 11,000g,
at room temperature for 2min, and ﬁltered through the NucleoSpin
ﬁlter. Then, 450 mL of buffer PC (binding solution) were added to
each lysate, mixed by gentle inversion and the volume eluted
through a spin column (NucleoSpin Plant II Column) by centrifu-
gation (1 min, 11,000 g at room temperature). The spin columnwas
washed three times with 400 mL of PW1 solution, 700 mL and 200 mL
of PW2 solution, followed by 1 min of centrifugation after the two
ﬁrst washes and a 2 min ﬁnal centrifugation (11,000 g at room
temperature). The elution step was performed twice with 50 mL of
PE solution at 65 C, followed by 5 min of incubation at 65 C and
centrifugation (1 min, 11,000g), in order to maximize DNA yield.
DNA extracts were immediately kept at 20 C until further anal-
ysis. The extractions were performed at least in duplicate for each
sample and mixture.
Yield and purity of extracts were assessed by 1% agarose gel
electrophoresis and by UV spectrophotometric DNA quantiﬁcation
on a Synergy HT multi-mode microplate reader (BioTek In-
struments, Inc., Vermont, USA), using a Take3 micro-volume plate
accessory. DNA content was determined using the nucleic acid
quantiﬁcation protocol with sample type deﬁned for double-strand
DNA in the Gen5 data analysis software version 2.01 (BioTek In-
struments, Inc., Vermont, USA).
2.4. Real-time PCR
Alcohol dehydrogenase gene (adh) was chosen as a marker for
maize quantiﬁcation since it is considered a taxon-speciﬁc
Table 1
Description of the plant food supplements (PFS) samples.
Samples Labeled information
PFS1 Hypericum perforatum 20%; Crataegus oxyacantha; Vitex agnus-castus; Angelica archangelica 6%; Passiﬂora incarnata 6%; Melissa ofﬁcinalis; Gelsemium
sempervirens; lactose; anti-agglomerating: tricalcium phosphate and magnesium stearate; wheat starch; magnesium chloride; vit. B6.
PFS2 Hypericum perforatum (extract of the aerial parts containing at least 900 mg of hypericin); capsule: gelatin; diluent: maltodextrin-19; lubricant: talc (magnesium
silicate); anti-agglomerating: silica (silicon dioxide).
PFS3 Hypericum perforatum (dry extract of the aerial parts approximately 185 mg/capsule); maltodextrin; lactose; anti-agglomerating: magnesium stearate; capsule:
gelatin; dyes: titanium dioxide and iron oxide
PFS4 Hypericum perforatum (extract of the aerial parts containing at least 900 mg of hypericin); gelatin; dicalcium phosphate; silica (silicon dioxide); vegetable
magnesium stearate.
PFS5 Garcinia cambogia 14.8%; Hypericum perforatum 11.1%; Glycine max: lecithin (14% phosphatidylinositol and 23% phosphatidylcholine); L-carnitine 9.3%;
microcrystalline cellulose 7.4%; Pyrus malus (pectin) 5.6%; lactose; anti-agglomerating: tricalcium phosphate, talc (magnesium silicate); chromium, trichloride
0.01%
Table 2
Description of mixtures of pharmaceutical excipients and respective results of real-time PCR quantiﬁcation of maize DNA (used as internal standard) based on 2 independent
extractions with n ¼ 8 replicates.
Mixtures Spiked maize DNA (ng) Composition of matrix Ct ± SDa DNA ± SDa (pg) CV (%) DNA recovery (%)
Control 50 Water 31.9 ± 0.1 418.2 ± 34.7 8.3 100
M0 (blank) 50 100% Celluloseb 33.7 ± 0.3 121.4 ± 24.9 20.5 29.0
M1 50 99% Cellulose, 1% silica 33.8 ± 0.5 122.2 ± 41.4 33.9 29.2
M2 50 90% Cellulose, 10% silica 37.3 ± 0.2 10.3 ± 1.4 13.4 2.5
M3 50 99% Cellulose, 1% talc 35.7 ± 0.4 29.9 ± 8.8 29.4 7.1
M4 50 90% Cellulose, 10% talc NA e e e
M5 50 98% Cellulose, 1% silica and 1% talc 34.6 ± 0.5 66.8 ± 21.4 32.0 16.0
M6 50 99.5% Cellulose, 0.5% titanium dioxide NA e e e
M7 50 99% Cellulose, 1% titanium dioxide NA e e e
M8 50 99.5% Cellulose, 0.5% iron oxide NA e e e
M9 50 99% Cellulose, 1% iron oxide NA e e e
M10 50 98% Cellulose, 1% iron oxide and 1% titanium dioxide NA e e e
a Cycle threshold (Ct) values are mean ± SD.
b Negative results were obtained without template maize DNA; SD, standard deviation; CV, coefﬁcient of variance; NA, no ampliﬁcation.
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primers (adh1-F, CCA GCC TCA TGG CCA AAG; adh1-R, CCT TCT TGG
CGG CTT ATC TG) and probe (adh1-P, FAM-CTT AGG GGC AGA CTC
CCG TGT TCC CT-BHQ1) targeting the adh1 genewere selected from
the literature [21].
Ampliﬁcations by real-time PCR were performed in 20 mL of
total reaction volume containing 2 mL of DNA extract, 1  of Sso-
Fast™ Probes Supermix, 200 nM of each primer adh1-F/adh1-R and
100 nM of adh1-P probe. The assays were carried out in a ﬂuoro-
metric thermal cycler CFX96 Real-time PCR Detection System
(BioRad, Hercules, CA, USA) using the following conditions: 95 C
for 5 min; 50 cycles at 95 C for 15 s and 60 C for 45 s, with
collection of ﬂuorescence signal at the end of each cycle. Data were
processed using the software Bio-Rad CFX Manager 3.1 (BioRad,
Hercules, CA, USA). Each extract was ampliﬁed in quadruplicate in
two independent assays.
3. Results and discussion
Following a preliminary study of our working group, in which
several PFS were tentatively submitted to DNA extraction using
different protocols (including in-house optimized extraction
methods and different commercial kits) that frequently resulted in
negative PCR ampliﬁcation targeting a eukaryotic gene,wedecide to
investigate the reasons behind this ﬁnding. Although ampliﬁable
DNA was extracted from several PFS, for others, negative results
were always obtained, irrespectively of the extraction method used
(unpublished data). In most of these PFS, the formulation label
described the inclusion of fragmented aerial plant parts, so it was
expectable the presence of extractable plant DNA. The PFS under
analysis were capsules and tablets that generally contain additional
materials, other than plants/plant extracts in their composition,
such as binders, diluents, glidants, lubricants, colorants andstabilizers. When carefully analyzing the ingredient list of the for-
mulations for which the extraction of ampliﬁable DNA was not
accomplished, we realized that most PFS had in common the in-
clusion of some excipients, namely talc and silica. It is known that
DNA can be adsorbed onto silica surfaces, being this phenomena the
basis for DNA puriﬁcation via solid-phase extraction used in several
commercial DNA extraction kits, and also by using silica nano-
particles [22e24]. The adsorption of DNA onto the surface of silica
nanoparticles used in DNA extraction from biological samples is
mainly explained by weak electrostatic repulsion forces, dehydra-
tion and hydrogen bonds [25,26]. Moreover, it has also been pro-
posed that adsorption of nucleic acids onto mineral surfaces can
occur due to ionic interactions between the negatively charged
phosphate groups of DNA and the positively charged surface groups
[27]. Thus, taking into account the adsorbent properties of talc [28],
it is possible that DNA could also be adsorbed to this excipient.
Moreover, based on the excipients listed from non-ampliﬁable PFS
extracts, other compounds, such as iron oxide and titanium dioxide,
used as colorants (dyes) in some formulations, could also have a
hampering effect on DNA extraction from PFS. According to the
available literature, iron oxide magnetic nanoparticles have already
been used for DNA adsorption to isolate it from mammalian cells
[29] and from herring sperm [30]. The adsorption of ﬂuorescent
labeledDNAoligonucleotides on titaniumdioxide nanoparticles has
been shown to take place mainly via the backbone phosphate [31].
Therefore, in the present work we intended to evaluate if the
referred pharmaceutical excipients (silica, talc, iron oxide and ti-
tanium dioxide) could be retaining DNA from PFS. For this purpose,
ﬁve selected PFS samples and eleven model excipient mixtures
were spiked with a known amount of maize DNA to work as an
internal standard. The samples and mixtures were then submitted
to DNA extraction and ampliﬁed by real-time PCR targeting a maize
DNA fragment for quantiﬁcation.
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The ﬁve PFS under study included one sample (PFS1) that gave
positive results for eukaryotic DNA ampliﬁcation (using themethod
described by Costa et al. [32]) and did not refer any of the phar-
maceutical excipients under evaluation, and four PFS (PFS2-PFS5)
that gave unsuccessful DNA ampliﬁcation (Table 1). To assess
possiblematrix effects, powdered ricewas used as a non-interfering
plant foodmatrix. Table 3 presents the results of the recovery assays
of maize DNA in water (control without matrix), rice and PFS sam-
ples determined by quantitative real-time PCR. As can be observed,
similar results were obtained for the control and the powdered rice
(442.9 pg and 416.6 pg maize DNA, respectively). Taking the water
control as reference, a high recovery of maize DNA (94%) was ob-
tained from the rice matrix, indicating a negligible effect of plant
material on DNA recovery. However, a much lower maize DNA
amount (184.2 pg) was obtained from the PFS1 sample, without any
of the excipients under evaluation, thus suggesting the existence of
a matrix effect on DNA ampliﬁcation that causes some inhibition
noticed in ampliﬁcation curve proﬁle. When compared to the con-
trol, more than 40% of maize DNAwas still recovered from the PFS1.
Regarding the other PFS, no DNA was recovered from the spiked
samples containing either talc (PFS2, PFS5) and/or silica (PFS2, PFS4)
in their composition, showing a complete retaining effect on maize
DNA extraction (Fig. 1A). In the case of PFS3, containing titanium
dioxide and iron oxide, onlyminute amounts ofmaizeDNA (15.7 pg)
were recovered. In this sample, titanium dioxide and iron oxide are
most likely to be present at very low amounts since both com-
pounds are generally used as coloring agents in pharmaceutical
formulations (1%). Possibly for this reason, the hampering effect
on DNA extraction was not as strong as in the PFS containing either
talc and/or silica, which are used at higher amounts (as lubricants,
gliders, binders or diluents) [20].
3.2. Mixtures of pharmaceutical excipients spiked with maize DNA
extract
Mixtures containing known amounts of the pharmaceutical
excipients hypothesized to be responsible for adsorption phe-
nomena were prepared using cellulose as diluent (Table 2). Iden-
tically to PFS samples, recovery assays were performed by adding
known amounts of maize DNA (50 ng) to the model mixtures.
Since talc is widely used in oral solid formulations as lubricant
(up to 10%) or as diluent (up to 30%) [20], initially, mixtures were
prepared with 10%e30% of talc in cellulose. Additionally, previous
mixtures containing 10% of talc added with different percentages of
the other excipients, namely 1% and 10% silica; 0.5% and 1% coloring
agents (titanium dioxide and iron oxide), were also prepared. In all
these assayed mixtures, no DNA was recovered since no ampliﬁca-
tions were obtained by real-time PCR targeting maize DNA,
evidencing a total adsorption of the spiked DNA to theTable 3
Real-time PCR quantiﬁcation of maize DNA (used as internal standard) spiked into diffe
replicates.
Matrix/sample Spiked maize DNA (ng) Pharmaceutical excipient under st
Control (water) 50 e
Rice ﬂourb 50 e
PFS1 50 e
PFS2 50 talc and silica
PFS3 50 titanium dioxide and iron oxide
PFS4 50 silica
PFS5 50 talc
a Cycle threshold (Ct) values are mean ± SD
b Negative results were obtained without template maize DNA; SD, standard deviatiopharmaceutical excipients used (data not shown). Thus, new and
different mixtures were prepared using lower amounts of each
excipient under study. Table 2 shows the composition of each
mixture and the respective maize DNA recovery results. As can be
observed, a low DNA amount was recovered from the 100% cellulose
material (blank) compared to the control (DNA inwater), pointing to
a possible interference of cellulose on DNA extraction (Fig. 1B).
Comparatively to the blankmaterial, all tested excipients showed the
capacity to adsorb DNA, although with different degrees (Fig. 1B and
C). Talc seems to exert a stronger hampering effect onDNA extraction
than silica. The mixture containing 1% of talc (M3) showed minute
amounts of recovered maize DNA (7.1%), while the 10% (M4)
completely adsorbed it. The 1% silica (M1) enabled a similar amount
of recovered DNA as the blank (M0), suggesting that at this level
none or negligible adsorption effect occurred. When silica was
increased to 10% (M2), there was a considerable DNA retention (2.5%
of recovery). Considering the mixture with both excipients at 1%
(M5), the amount of recovered DNA reached an intermediate value
(16.0%) between M1 and M3 with 1% silica or 1% talc, respectively
(Table 2). In this case, it was expected a higher retention effect than
using only 1% of talc, which suggest that both excipientsmay interact
and decrease the DNA adsorption.
Regarding the mixtures containing different amounts of the
dyes titanium dioxide and iron oxide (M6-M10), no ampliﬁcation
was obtained, showing a complete DNA retention in all the cases
(Table 2). These results are in good agreement with previous data
that reported a very strong interaction between DNA and particles
of cobalt ferrite (a compound composed of iron oxide) due to the
high afﬁnity of phosphate groups to iron oxides [22].
Generally, the results from model excipient mixtures (Table 2)
support the ﬁndings obtained in the analyzed PFS (Table 3),
regarding the presence or absence of the tested excipients. The
presence of bulk or diluent agents such as cellulose (M0) or starch
(PFS1) prompts high and close DNA adsorption phenomena. The
absence of DNA ampliﬁcation in the PFS2, PFS4 and PFS5 might be
explained by the use of talc and/or silica at levels 10%, while
minute amount of recovered DNA in PFS3 might result from the
presence of titanium dioxide and iron oxide at lower proportions
than 0.5%. It is also important to highlight that the presence of other
non-tested components/excipients in the PFS formulations might
contribute for synergic or antagonist interactions.
In conclusion, the results evidenced a clear adsorption phenom-
enawith all the tested excipients (silica, talc, iron oxide and titanium
oxide) that could justify the hampering effect on DNA extraction
from PFS. Thus, when evaluating the results obtained for DNA ana-
lyses in PFS, researchers must consider the formulations and excip-
ients described on the products label, as those can affect the outcome
of analyses. Since most PFS are sold as capsules and tablets, which
frequently include the tested pharmaceutical excipients, further
research is required in order to identify a strategy to release plant
DNA from such formulations for forthcoming authenticity purposes.rent matrixes (water, rice and PFS) based on 2 independent extractions with n ¼ 8
udy Ct ± SD DNA ± SDa (pg) CV (%) DNA recovery (%)
32.34 ± 0.22 442.9 ± 64.9 14.6 100
32.44 ± 0.26 416.6 ± 72.6 17.4 94.1
33.63 ± 0.09 184.2 ± 11.8 6.4 41.6
NA e e e
37.35 ± 0.31 15.7 ± 4.6 29.5 3.5
NA e e e
NA e e e
n; CV, coefﬁcient of variance; NA, no ampliﬁcation.
Fig. 1. Ampliﬁcation curves obtained by real-time PCR targeting adh gene of maize used as internal DNA standard spiked to plant food supplements (PFS) (A) and to pharmaceutical
model mixtures (B, C). PFS1-PFS5, samples of PFS as described in Table 1; M0-M10, model mixtures as described in Table 2.
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